Sandoz Reveals Biosimilar Denosumab Program

 
• By David Wallace
  
Denosumab
Sandoz has revealed details of a trial for biosimilar denosumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products